FTC schedules workshop on drug/biotech M&A: https://www.ftc.gov/news-events/news/press-releases/2022/05/ftc-justice-department-hold-two-day-virtual-public-workshop-re-examining-antitrust-enforcement Some of the current FTC commissioners are on record as having opposed to the BMY-CELG and ABBV-AGN deals, among others.